Prospective phase II study of inoperable pancreatic adenocarcinoma with neoadjuvant gemcitabine, docetaxel, and capecitabine (GTX).
Anthony Paul Gulati
No relevant relationships to disclose
Stephen M. Schreibman
No relevant relationships to disclose
Beth Schrope
No relevant relationships to disclose
James A. Lee
No relevant relationships to disclose
John Allendorf
No relevant relationships to disclose
John A. Chabot
No relevant relationships to disclose
Dawn Tsushima
No relevant relationships to disclose
Kelley B. Mowatt
No relevant relationships to disclose
Anna Oprescu
No relevant relationships to disclose
Kyung Chu
No relevant relationships to disclose
William H. Sherman
No relevant relationships to disclose
Ronald D. Ennis
No relevant relationships to disclose
Yoomi Lee
No relevant relationships to disclose
Robert Lance Fine
No relevant relationships to disclose